Colorectal cancer, also known as bowel cancer, colorectal adenocarcinoma, or colon cancer, is a type of cancer that results from uncontrolled growth of the cells of rectum or colon. Factors such as growing geriatric population, rising prevalence of colorectal cancer, technological advancement, introduction of non-invasive screening tests are driving the growth of the global in-vitro colorectal cancer screening tests market. This report studies the current scenario as well as future market potential for in-vitro colorectal cancer screening tests globally. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.
A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global in-vitro colorectal cancer screening tests market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players (%) operating in the in-vitro colorectal cancer screening tests market.
This exhaustive report includes a 360° view of the In-vitro Colorectal Cancer Screening Tests Market. Browse through this 95-page report to know what factors will shape the market during the period 2015-2023
Based on tests type, the global in-vitro colorectal cancer screening tests market has been segmented into fecal occult blood tests, stool biomarkers tests, and blood biomarkers tests. The market for these test types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the in-vitro colorectal cancer screening tests market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.
Geographically, the in-vitro colorectal cancer screening tests market has been categorized into North America, Europe, Asia-Pacific, Latin America, and Rest of the World. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the in-vitro colorectal cancer screening tests market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Molecular, Inc., Alere, Inc, Beckman Coulter, Inc., Epigenomics AG, Sysmex Corporation, Quest Diagnostics, Exact Sciences Corporation, Novigenix SA, CML Healthcare, Inc., and BioTime, Inc.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving In-vitro Colorectal Cancer Screening Tests Market during 2015- 2023
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453